Form 4: USANA Health Sciences COO Walter Noot Sells All Remaining Shares Through Pre-Arranged Plan

USANA Health Sciences' Chief Operating Officer, Walter Noot, reported the sale of 6,291 shares of common stock on May 27, 2025, through a Rule 10b5-1 trading plan, resulting in zero beneficial ownership.

Summary

• Walter Noot, the Chief Operating Officer of USANA Health Sciences Inc. (USNA), reported the disposition of common stock.
• The transaction involved the sale of 6,291 shares of USANA Health Sciences common stock.
• The sale occurred on May 27, 2025, at a weighted average price of $30.2921 per share, with prices ranging from $30.25 to $30.39.
• This transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan, indicating a pre-arranged sale.
• Following this reported transaction, Walter Noot's beneficial ownership of USANA Health Sciences common stock is 0 shares.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to a key executive selling all their shares, which can be perceived as a lack of confidence or alignment. However, the negative impact is mitigated by the fact that the sale was pre-arranged under a Rule 10b5-1 plan, indicating it was not based on immediate, undisclosed information.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, which indicates the sale was pre-scheduled and not based on immediate, non-public information, enhancing transparency and mitigating concerns about opportunistic insider trading.

Negatives

• The Chief Operating Officer, Walter Noot, has disposed of all his beneficially owned shares, resulting in zero ownership, which could be perceived negatively by investors as a lack of alignment with shareholder interests or a signal about future company prospects.
• Insider selling, particularly a full divestment, can sometimes lead to negative market sentiment, regardless of the reason.

Risks

• Potential for negative market perception or misinterpretation of the insider sale, which could put downward pressure on the stock price.
• Reduced alignment of the Chief Operating Officer's personal financial interests with the long-term performance of the company due to zero share ownership.

Future Outlook

The document does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This filing is specific to an individual insider transaction and does not provide broader industry context or trends. It reflects an individual executive's decision regarding their personal equity holdings in the company.

Stakeholder Impact

• Shareholders may react to the news of a key executive selling all their shares, potentially leading to a decrease in investor confidence or a short-term negative impact on the stock price.

Key Dates

Recommendation

Keywords

USANA Health Sciences, USNA, Form 4, Insider Trading, Stock Sale, Walter Noot, Chief Operating Officer, 10b5-1 plan, Beneficial Ownership